FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
| MK-0852, 138199-64-1, MK-0852 Intermediate /, stock 297.6g, white powder, assay by HPLC 98.6%, HNMR, LCMS we supply. |
| MK-0852, 138199-64-1, MK-0852 Intermediate /, stock 548.9g, white powder, assay by HPLC 98.1%, HNMR, LCMS we supply. |
| MK-0852, 138199-64-1, MK-0852 Intermediate /, stock 809.3g, white powder, assay by HPLC 99.8%, HNMR, LCMS we supply. |
| MK-0852, 138199-64-1, MK-0852 Intermediate 17201-43-3, stock 791.2g, white powder, assay by HPLC 98.8%, HNMR, LCMS we supply. |
| MK-0852, 138199-64-1, MK-0852 Intermediate 1068-90-2, stock 599.8g, white powder, assay by HPLC 99.3%, HNMR, LCMS we supply. |
| MK-0852, 138199-64-1, MK-0852 Intermediate /, stock 608.5g, white powder, assay by HPLC 98.7%, HNMR, LCMS we supply. |
| MK-0852, 138199-64-1, MK-0852 Intermediate /, stock 183.2g, white powder, assay by HPLC 98.1%, HNMR, LCMS we supply. |
| MK-0852, 138199-64-1, MK-0852 Intermediate 150338-17-3, stock 429.4g, white powder, assay by HPLC 98.2%, HNMR, LCMS we supply. |
| MK-0852, 138199-64-1, MK-0852 Intermediate 150338-18-4, stock 358.9g, white powder, assay by HPLC 99.6%, HNMR, LCMS we supply. |
| MK-0852, 138199-64-1, MK-0852 Intermediate 150338-19-5, stock 106.9g, white powder, assay by HPLC 99.9%, HNMR, LCMS we supply. |
| MK-0852, 138199-64-1, MK-0852 Intermediate 138199-64-1, stock 629.1g, white powder, assay by HPLC 98.9%, HNMR, LCMS we supply. |
